Project Details
Description
To determine the efficacy of D-Penicillamine in the treatment of primary sclerosing cholangitis, 70 pts have been entered into a double blind controlled trial comparing placebo vs 750 mg of D-Penicillamine and
have been followed annually by clinical, biochemical, hepatic,
histologic, and radiologic criteria.
have been followed annually by clinical, biochemical, hepatic,
histologic, and radiologic criteria.
Status | Finished |
---|---|
Effective start/end date | 12/1/76 → 11/30/09 |
ASJC
- Medicine(all)